Outcome on quality of life in a Canadian national sample of patients with schizophrenia and related psychotic disorders

Acta Psychiatrica Scandinavica

Volumn 113, Issue SUPPL. 430, 2006, Pages 22-28

  Malla, A ^a,d   Williams, R ^b   Kopala, L ^b   Smith, G ^b   Talling, D ^c   Balshaw, R ^c  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Syreon Corporation   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Outcome; Quality of life; Schizophrenia

Indexed keywords

ARTICLE; CANADA; DATA ANALYSIS; HEALTH STATUS; HUMAN; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; QUESTIONNAIRE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; TIME SERIES ANALYSIS; TREATMENT OUTCOME;

EID: 33645101639     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2006.00758.x     Document Type: Article

References (24)

1. C ollins EJ H ogan TP D esai H Measurement of therapeutic response in schizophrenia. A critical survey Schizophr Res 1991 5 249 253
2. C arpenter WT Jr. H einrichs DW H anlon TE Methodologic standards for treatment outcome research in schizophrenia Am J Psychiatry 1981 138 465 471
3. L ehman AF The effects of psychiatric symptoms on quality of life assessments among the chronic mentally ill Eval Program Plann 1983 6 143 151
4. A ttkisson C C ook J K arno M et al Clinical services research Schizophr Bull 1992 18 561 626
5. B rowne S R oe M L ane A et al Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia Acta Psychiatr Scand 1996 94 118 124
6. L ehman AF Measures of quality of life among persons with severe and persistent mental disorders Soc Psychiatry Psychiatr Epidemiol 1996 31 78 88
7. M eltzer HY B urnett S B astani B R amirez LF Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients Hosp Community Psychiatry 1990 41 892 897
8. T homas CS L ewis S Which atypical antipsychotic Br J Psychiatry 1998 172 106 109
9. W ilson IB C leary PD Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes JAMA 1995 273 59 65
10. C orrigan PW B uican B The construct validity of subjective quality of life for the severely mentally ill J Nerv Ment Dis 1995 183 281 285
11. C leary PD Future directions of quality of life research In S ilker B ed Quality of life and pharmacoeconomics in clinical trials Philadelphia, PA Lippincott-Raven 1996 73 78
12. A ngermeyer MC K atschnig H Theoretical models of quality of life for mental disorders In K atschnig H F reeman H S artorius N eds Quality of life in mental disorders New York Wiley 1997 19 30
13. K atschnig H How useful is the concept of quality of life in psychiatry In K atschnig H F reeman H S artorius N eds Quality of life in mental disorders New York Wiley 1997 3 15
14. B rowne S C larke M G ervin M W addington JL L arkin C O'C allaghan E Determinants of quality of life at first presentation with schizophrenia Br J Psychiatry 2000 176 173 176
15. B obes J G onzales M Quality of life in schizophrenia In K atschnig H F reeman H S artorius N eds Quality of life in mental disorders New York Wiley 1997 165 178
16. B ecker M D iamond R S ainfort F A new patient focused index for measuring quality of life in persons with severe and persistent mental illness 1993 Qual Life Res 1993 2 239 251
17. M alla AK N orman RM M c L ean TS M c I ntosh E Impact of phase-specific treatment of first episode of psychosis on Wisconsin Quality of Life Index (client version) Acta Psychiatr Scand 2001 103 355 361
18. M alla AK N orman RM M c L ean TS et al Determinants of quality of life in first-episode psychosis Acta Psychiatr Scand 2004 109 46 54
19. B ecker M D iamond R New developments in quality of life measurement in schizophrenia In K atschnig H F reeman H S artorius N eds Quality of life in mental disorders New York Wiley 1997 133 199
20. W are JE Jr. G andek B Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project J Clin Epidemiol 1998 51 903 912
21. V oruganti L C ortese L O yewumi L C ernovsky Z Z irul S A wad A Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life Schizophr Res 2000 43 135 145
22. C ook PE G oldberg JO V an L ieshout RJ. Benefits of switching from typical to atypical antipsychotic medications: a longitudinal study in a community-based setting Can J Psychiatry 2002 47 870 874
23. S mith G M alla A W illiams R K opala L L ove L B alshaw R. The Canadian national outcomes measurement study in schizophrenia: overview of the patient sample and methodology Acta Psychiatr Scand 2006 113 (Suppl. 430) 2 9
24. H arrison G H opper K C raig T et al Recovery from psychotic illness: a 15- and 25-year international follow-up study Br J Psychiatry 2001 178 506 517